Yes: Rsv prophylaxis only protects against pneumonia. With the new drug motavizumab the lokelihood fir upper resp tract infection is lower. Keep in mind that there is no immunity after the prophylaxis. Its an antibody. Not a vaccine. The concentration drops after administration and needs to be repeated.
Answered 7/2/2014
5.7k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question